Remission in prognosis of functional outcome: A new dimension in the treatment of patients with psychotic disorders

Schizophrenia Research

Volumn 93, Issue 1-3, 2007, Pages 160-168

  Helldin, Lars ^a   Kane, John M ^b   Karilampi, Ulla ^c   Norlander, Torsten ^d   Archer, Trevor ^c,e  

^a NU Health Care Trollhattan   (Sweden)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF GOTHENBURG   (Sweden)

^d KARLSTAD UNIVERSITY   (Sweden)

^e LINNAEUS UNIVERSITY   (Sweden)

Author keywords

Daily living; Health care; Patients with schizophrenia; Remission; Social functioning

Indexed keywords

ADULT; ARTICLE; COST OF ILLNESS; DAILY LIFE ACTIVITY; DEMENTIA; DISEASE SEVERITY; EDUCATION; FAMILY; FEMALE; FUNCTIONAL STATUS; HEALTH CARE NEED; HEALTH CARE UTILIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; POSITIVE AND NEGATIVE SYNDROME SCALE; PRIORITY JOURNAL; PROGNOSIS; PSYCHOSIS; REMISSION; SCHIZOPHRENIA; SOCIAL NETWORK; SOCIAL STATUS; SOCIAL SUPPORT; SWEDEN;

ACTIVITIES OF DAILY LIVING; ADULT; ANTIPSYCHOTIC AGENTS; CHRONIC DISEASE; COMBINED MODALITY THERAPY; DELUSIONS; FEMALE; HUMANS; LENGTH OF STAY; MALE; MENTAL HEALTH SERVICES; MIDDLE AGED; PATIENT READMISSION; PROGNOSIS; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTIC DISORDERS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SOCIAL ADJUSTMENT; SOCIAL SUPPORT; SWEDEN; TREATMENT OUTCOME; UTILIZATION REVIEW;

EID: 34249314745     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.schres.2007.01.014     Document Type: Article

References (38)

1. Andreasen N.C. Negative symptoms in schizophrenia. Arch. Gen. Psychiatry 39 7 (1982) 784-788
2. Andreasen N.C., and Olsen S. Negative v positive schizophrenia. Definition and validation. Arch. Gen. Psychiatry 39 7 (1982) 789-794
3. Andreasen N.C., Carpenter W., Kane J.M., Lasser R.A., Marder S.R., and Weinberger D.R. Remission in schizophrenia: proposed criteria and rationale for consensus. Am. J. Psychiatry 162 (2005) 441-449
4. Bakish D. New standard of depression treatment: remission and full recovery. J. Clin. Psychiatry 62 suppl. 26 (2001) 5-9
5. Ballenger J.C. Treatment of anxiety disorders to remission. J. Clin. Psychiatry 62 suppl. 1 (2001) 5-9
6. Barnes T.R., and Curson D.A. Long-term depot antipsychotics. A risk-benefit assessment. Drug Safety 10 6 (1994) 464-479
7. Chen Y.R., Swann A.C., and Johnson B.A. Stability of diagnosis in bipolar disorder. J. Nerv. Ment. Dis. 186 1 (1998) 17-23
8. Ericson B.G., Hansson J.-H., and Teike T. Urgent need for a need assessment scale in monitoring social support. A validation study on the Swedish version of the Camberwell Assessment of Need. Nord. J. Psychiatry 51 (1997) 173-182
9. Fenton W.S., and McGlashan T.H. Natural history of schizophrenia subtypes. II. Positive and negative symptoms and long-term course. Arch. Gen. Psychiatry 48 11 (1991) 978-986
10. Fleischhacker W.W., Eerdekens M., Karcher K., Remington G., Llorca P.M., Chrzanowski W., Martin S., and Gefvert O. Treatment of schizophrenia with long-acting injectable risperidone: a 12-month open-label trial of the first long-acting second-generation antipsychotic. J. Clin. Psychiatry 64 10 (2003) 1250-1257
11. Frank E., Prien R.F., Jarrett R.B., Keller M.B., Kupfer D.J., Lavori P.W., Rush A.J., and Weisman M.M. Conceptualisation and rationale for consensus definitions of terms in major depressive disorder. Remission, recovery, relapse and recurrence. Arch. Gen. Psychiatry 48 (1991) 851-855
12. Hamilton M. A rating scale for depression. J. Neurol. Neurosurg. Psychiatry 23 (1960) 56-62
13. Hansson L., Björkman T., and Svensson B. The assessment of needs in psychiatric patients. Interrater reliability of the Swedish version of the Camberwell Assessment of Needs instrument and results from a cross-sectional study. Acta Psychiatr. Scand. 92 (1995) 285-293
14. Helldin L., Kane J.M., Karilampi U., Norlander T., and Archer T. Remission and cognitive ability in a cohort of patients with schizophrenia. J. Psychiatr. Res. 40 (2006) 738-745
15. Hollis C. Adult outcomes of child- and adolescent-onset schizophrenia: diagnostic stability and predictive validity. Am. J. Psychiatry 157 10 (2000) 1652-1659
16. Janson S. National asthma education and prevention program, expert panel report. II: Overview and application to primary care. Lippincott's Prim. Care Pract. 2 (1998) 578-588
17. Kane J.M., Leucht S., Carpenter D., and Docherty J.P. Expert consensus guideline series. Optimizing pharmacologic treatment of psychotic disorders. Introduction: methods, commentary, and summary. J. Clin. Psychiatry 64 suppl. 12 (2003) 5-19
18. Kay S.R., and Opler L.A. The positive-negative dimension in schizophrenia: Its validity and significance. Psychiatr. Dev. 2 (1987) 79-103
19. Kay S.R., Fitzbein A., and Opler L.A. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr. Bull. 13 (1987) 261-267
20. Kay S.R., Opler L.A., and Lindenmayer J.P. Reliability and validity of the positive and negative syndrome scale for schizophrenia. Psychatr. Res. 23 (1988) 99-110
21. Keller M.B. Past, present and future directions for defining optimal treatment outcome in depression. Remission and beyond. JAMA 289 (2003) 3152-3160
22. Liberman R.P., Kopelowicz A., Venture J., and Gutkind D. Operational criteria and factors related to recovery from schizophrenia. Int. Rev. Psychiatry 14 (2002) 256-272
23. Liberman R.P., Glynn S., Blair K.E., Ross D., and Marder S.R. In vivo amplified skills training: promoting generalization of independent living skills for clients with schizophrenia. Psychiatry 65 2 (2002) 137-155
24. Lindstrom E., Wieselgren I.M., and von Knorring L. Interrater reliability of the Structured Clinical Interview for the Positive and Negative Syndrome Scale for schizophrenia. Acta Psychiatr. Scand. 89 3 (1994) 192-195
25. Loffler W., Kilian R., Toumi M., and Angermeyer M.C. Schizophrenic patients' subjective reasons for compliance and noncompliance with neuroleptic treatment. Pharmacopsychiatry 36 3 (2003) 105-112
26. Marneros A., Deister A., and Rohde A. Stability of diagnoses in affective, schizoaffective and schizophrenic disorders. Cross-sectional versus longitudinal diagnosis. Eur. Arch. Psychiatry Clin. Neurosci. 241 3 (1991) 187-192
27. McGlashan T.H., and Fenton W.S. The positive-negative distinction in schizophrenia. Review of natural history validators. Arch. Gen. Psychiatry 49 1 (1992) 63-72 [Jan]
28. O'Donnell C., Donohoe G., Sharkey L., Owens N., Migone M., Harries R., Kinsella A., Larkin C., and O'Callaghan E. Compliance therapy: a randomised controlled trial in schizophrenia. BMJ 327 7419 (2003) 834
29. Overall J.E., and Gorham D.R. The Brief Psychiatric Rating Scale. Psychol. Rep. 10 (1962) 799-812
30. Phelan M., Slade M., Thornicroft G., Dunn G., Holloway F., Wykes T.H., et al. The Camberwell Assessment of Need: the validity and reliability of an instrument to assess the needs of people with severe mental illness. Br. J. Psychiatry 167 (1995) 589-595
31. Romney D.M. A simplex model of the paranoid process: implications for diagnosis and prognosis. Acta Psychiatr. Scand. 75 6 (1987) 651-655
32. Singer P.A., Cooper D.S., Levy E.G., Ladenson P.W., Braverman L.E., Daniels G., Greenspan F.S., McDougall I.R., and Nikolai T.F. Treatment guidelines for patients with hyperthyroidism and hypothyroidism. Standards of Care Committee, American Thyroid Association. JAMA 273 (1995) 808-812
33. Slade M., Thornicroft G., Loftus L., Phelan M., and Wykes T. CAN: Camberwell Assessment of Need. A Comprehensive Needs Assessment Tool for People with Severe Mental Illness (1999), Gaskell, London
34. Strauss J.S., and Carpenter W.T. The prediction of outcome in schizophrenia I: characteristics of outcome. Arch. Gen. Psychiatry 27 (1972) 739-746
35. Tsuang M.T., Woolson R.F., Winokur G., and Crowe R.R. Stability of psychiatric diagnosis. Schizophrenia and affective disorders followed up over a 30- to 40-year period. Arch. Gen. Psychiatry 38 5 (1981) 535-539
36. Van Os J., Burns T., Cavallaro R., Leucht S., Peuskens J., Helldin L., Bernardo M., Arango C., Fleischhacker W., Lachaux B., and Kane J.M. Standardized remission criteria in schizophrenia. Acta Psychiatr. Scand. (2006) 91-95
37. Williams B., Poulter N.R., Brown M.J., Davis M., McInnes G.T., Potter J.F., Sever P.S., and McG Thom S. Guidelines for management of hypertension: report of the fourth working party of the British Hypertension Society, 2004-BHS IV. J. Hum. Hypertens. 18 (2004) 139-185
38. Zygmunt A., Olfson M., Boyer C.A., and Mechanic D. Interventions to improve medication adherence in schizophrenia. Am. J. Psychiatry 159 10 (2002) 1653-1664